Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)
Condition: Eustachian Tube Dysfunction Interventions: Drug: Fluticasone Propionate 93 MCG/1 ACTUATION Nasal Spray; Other: Placebo Nasal Spray Sponsor: Cedars-Sinai Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2022 Category: Research Source Type: clinical trials
Effect of acupuncture therapy combined with fluticasone propionate in the treatment of persistent allergic rhinitis: study protocol for a randomized controlled trial
This study is a multicenter, single-blind, randomized controlled trial. A total of 260 eligible patients will be randomly assigned into the treatment group or the control group. The treatment group will receive the nasal fluticasone propionate combined with acupuncture, and the control group will receive fluticasone propionate nasal spray alone for 6 weeks. The primary outcome is the change in the Reflective Total Nasal Symptom Score (rTNSS) from baseline to the end of treatment, and the Total Non Nasal Symptom Score (TNNSS), reflective total ocular symptom score (rTOSS), Rhinitis Quality of Life Questionnaire (RQLQ), u...
Source: Trials - January 31, 2022 Category: Research Source Type: clinical trials
A Study in the US Based on Pharmacy and Medical Claims That Compares How Well Stiolto ® and Trelegy® Work in People With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive Interventions: Device: Trelegy Ellipta; Device: Stiolto Respimat; Drug: Tiotropium + Olodaterol (5/5 mcg); Drug: Fluticasone Furoate + Umeclidinium + Vilanterol (100/62.5/25 mcg) Sponsor: Boehringer Ingelheim Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2021 Category: Research Source Type: clinical trials
